AddLife AB's revenue for the
three
months ended in Mar. 2024 was kr2,570 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr9,798 Mil.
AddLife AB's Revenue per Share for the
three
months ended in Mar. 2024 was kr21.09.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr80.40.
Warning Sign:
AddLife AB revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of AddLife AB was 10.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 19.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 28.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 26.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 11 years, AddLife AB's highest 3-Year average Revenue per Share Growth Rate was 39.30% per year. The lowest was 16.40% per year. And the median was 27.70% per year.
AddLife AB Revenue Historical Data
The historical data trend for AddLife AB's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AddLife AB's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AddLife AB's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Revenue distribution charts can be found below:
* The bar in red indicates where AddLife AB's Revenue falls into.
AddLife AB Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9,798 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AddLife AB (OSTO:ALIF B) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
AddLife AB Revenue Related Terms
Thank you for viewing the detailed overview of AddLife AB's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:ALIF B has been successfully added to your 